Ignite Creation Date:
2025-12-24 @ 11:58 AM
Ignite Modification Date:
2026-01-07 @ 5:15 PM
Study NCT ID:
NCT02732561
Status:
COMPLETED
Last Update Posted:
2018-10-16
First Post:
2016-03-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Efficacy of Cranial Electrostimulating Therapy for Depression and Anxiety Among Homeless Adults
Sponsor:
Wake Forest University Health Sciences
Organization:
Study Overview
Official Title:
The Efficacy of Cranial Electrostimulating Therapy for Depression and Anxiety
Status:
COMPLETED
Status Verified Date:
2018-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a trial of the use of cranial electrostimulating therapy for depression and anxiety among homeless adults.
Detailed Description:
Cranial Electrostimulating (CES) Therapy is a Food and Drug Administration (FDA) approved treatment for depression and anxiety. However, there are no known studies on the use of this device with homeless adults. The objectives of this study are as follows: 1) to evaluate the acceptability and feasibility of CES as a treatment for homeless adults; and 2) to evaluate the efficacy of CES for the treatment of anxiety and depressive symptoms among homeless adults. Participants will be randomly assigned to one of two treatments: sham (n=10) or CES (n=10). Changes in anxiety and depressive symptoms will be evaluated over time.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: